WP-A-Highly-Reproducible-In-Vivo-Model-for-Bleomycin-Induced-Lung-Fibrosis-in-Mice-to-Evaluate-Drugs-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis

A Highly Reproducible In Vivo Model for Bleomycin-Induced Lung Fibrosis in Mice to Evaluate Drugs for the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a type of chronic lung disease characterized by a progressive and irreversible decline in lung function.

Aragen has a portfolio of in vivo fibrosis models, we offer customised and high quality animal models with ex vivo readouts to support our clients anti-fibrosis drug development.

Download our whitepaper which highlights three case studies:

Differential Analysis of Infiltrating Leukocytes from BAL Harvest plus Changes in Histology
Changes in Lung Function in Bleomycin-Induced IPF
Efficacy of a Small Molecule Compound in Bleomycin-Induced IPF

Please fill the form to download the whitepaper

✽

By submitting this form you agree to our Privacy Policy concerning the way Aragen may use your personal information.

.